BlueStone IPO 2025: GMP, Price Band, Subscription Status & Should You Invest?
BlueStone IPO 2025 – Check latest Grey Market Premium (GMP), price band, lot size, subscription status, and expert investment analysis. Stay informed with BlueStone IPO dates, company financials, and listing expectations.

The BlueStone Jewellery IPO 2025 is creating buzz among investors as one of the most awaited public listings in India’s jewellery sector. With a size of ₹1,541 crore and a growing digital-first brand presence, this IPO has caught the attention of retail and institutional investors alike.
But is it worth applying? Let’s break down the price band, GMP (Grey Market Premium) trends, subscription status, company fundamentals, and expert investment views in a simple, reader-friendly way.
BlueStone Jewellery IPO 2025 — At a Glance
Particulars | Details |
---|---|
IPO Size | ₹1,540.65 crore |
Fresh Issue | ₹820 crore |
Offer for Sale (OFS) | ₹720.65 crore |
Price Band | ₹492 – ₹517 per share |
Lot Size | 29 shares |
Minimum Investment | ₹14,993 |
IPO Open Date | August 11, 2025 |
IPO Close Date | August 13, 2025 |
Allotment Date | August 14, 2025 |
Expected Listing Date | August 19, 2025 |
Promoter Holding Post-IPO | Falls from ~18.3% to ~16.4% |
What is BlueStone Jewellery?
BlueStone Jewellery and Lifestyle Ltd. is a leading digital-first, omni-channel jewellery brand in India. Known for its trendy designs and customisation options, BlueStone offers:
-
Gold, diamond, platinum, and gemstone jewellery
-
Both online sales (via app and website) and offline retail presence
-
Over 275 stores in 117 cities across India
Founded with the aim to blend modern design with traditional craftsmanship, the brand has built strong recall among urban millennials and Gen Z buyers.
Grey Market Premium (GMP) — Current Buzz
GMP Today: Around ₹9 per share
➡ This translates to a 1.74–2% premium over the upper price band.
GMP Trend:
-
Earlier: ₹11 per share (~2.1% premium)
-
Current: ₹9 per share (~1.7–2% premium)
-
Some unverified reports claim ₹35, but these seem outdated and not in line with market sentiment.
What This Means:
A low GMP indicates muted listing expectations, suggesting the stock may not see a major “listing pop” on debut.
Subscription Status — Investor Response So Far
Day | Total Subscription | Retail | NII (HNI) | QIB |
---|---|---|---|---|
Day 1 | 39–44% | ~38–64% | 4–6% | 57% |
Day 2 | 53% | 70% | 22% | 63–85% |
Key Observations:
-
Day 1: Tepid retail participation, stronger QIB interest.
-
Day 2: Institutional demand continues, retail picks up slightly.
-
Still far from oversubscription levels seen in hot IPOs.
BlueStone Jewellery — Financial Performance
-
Valuation: Around ₹7,800 crore post-listing
-
Revenue Growth: Strong YoY growth, with a sharp rise in average order value (~22% CAGR)
-
Profitability: Losses have widened from ₹167 crore (FY23) to ₹222 crore (FY25)
-
Inventory: High stock levels may impact cash flow
Strengths (Pros)
-
Strong Brand Recall in urban and premium jewellery segment
-
Omni-channel strategy — online + offline store network
-
Fast revenue growth and improving unit economics
-
High anchor investor participation (~₹693 crore booked before IPO)
Risks (Cons)
-
Consistent net losses — not yet profitable
-
High inventory levels — may hurt margins
-
Low GMP — limited listing gains likely
-
Moderate subscription so far — not a sign of aggressive demand
Should You Invest?
Investor Profile | Suggested Approach |
---|---|
Long-Term Investor | Consider applying if you believe in India’s jewellery consumption growth and BlueStone’s brand strength. |
Short-Term Trader | Avoid — low GMP suggests limited listing gains. |
Risk-Averse | Wait and watch — enter post-listing after price stability. |
Important IPO Dates Recap
-
Bidding Period: Aug 11–13, 2025
-
Allotment: Aug 14, 2025
-
Listing: Aug 19, 2025
Expert Take
BlueStone is a growth-stage consumer brand with a powerful market presence but yet-to-be-proven profitability. If your focus is long-term wealth creation and you’re comfortable with short-term volatility, this IPO could be an attractive bet.
However, if your goal is quick listing gains, current market sentiment suggests this may not be the right play.
Final Verdict
-
For Long-Term Growth: Worth considering
-
For Short-Term Gains: Skip this one
-
Caution: Keep an eye on QIB subscription on the final day — strong institutional demand could still surprise on listing.